Crossref
Venetoclax plus azacitidine as a bridge treatment to allogeneic stem cell transplantation in acute myeloid leukaemia patients
Transfuze a hematologie dnes · 10.03.2026 · 32 (1)
DOI: 10.48095/cctahd202604 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfuze a hematologie dnes, online erschienen am 06.03.2026. Verfasst von Martin Čerňan und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Čerňan, M., & Szotkowski, T. (2026). Venetoclax plus azacitidine as a bridge treatment to allogeneic stem cell transplantation in acute myeloid leukaemia patients. Transfuze a hematologie dnes, 32(1). https://doi.org/10.48095/cctahd202604
Vancouver
Čerňan M, Szotkowski T. Venetoclax plus azacitidine as a bridge treatment to allogeneic stem cell transplantation in acute myeloid leukaemia patients. Transfuze a hematologie dnes. 2026;32(1). doi:10.48095/cctahd202604
BibTeX
@article{eran2026,
author = {Čerňan, Martin and Szotkowski, Tomáš},
title = {Venetoclax plus azacitidine as a bridge treatment to allogeneic stem cell transplantation in acute myeloid leukaemia patients},
journal = {Transfuze a hematologie dnes},
year = {2026},
volume = {32},
number = {1},
doi = {10.48095/cctahd202604}
}
EUVIMED